Current Month 2005
Article Features
  Breast Cancer Risk Increased for African-Americans with Mitochondrial DNA Variant
New Analytical Tool Helps Detect Cancer
Does Surgery Induce Angiogenesis in Dormant Breast Cancer?
CAD Helps Detect Smaller, Potentially More Aggressive Breast Cancers in Younger Women
Hormone Replacement Therapy Associated With Increases in Mammographic Breast Density
Increased Ovarian Cancer Risk Not Found in Women with Breast Cancer Family History
Postmenopausal Hormone Therapy Increases Breast Cancer Risk Across All Ethnicities
Tissue Stiffness Drives Tumor Formation
Study Finds Depression and Fatigue Not Associated with Cancer Risk
Enzyme Linked to Spread of Breast Cancer Cells
Researchers Zero in on Estrogenís Role in Breast Cancer Cell Growth
Letrozole Following Tamoxifen May Benefit Women with Breast Cancer
Scientists Identify Gene Involved in Breast Development
New Herceptin Results Confirm Reduction in Risk of Cancer Returning
Hormone Replacement Therapy Associated With Increases in Mammographic Breast Density
Immune Cells in Lymph Nodes Can Predict Risk of Breast Cancer Recurrence
Many Women Who Get Mammograms Fail To Return for Routine Screenings
Protein Linked to Growth of Organs and Cancer
Status of Progesterone Receptor May Be Important Factor in Breast Cancer
Weight Loss Decreases Risk of Breast Cancer in Susceptible Women
Protein Rich Diet Boosts Benefit of Exercise and Weight Loss


Breast Cancer Screening Trial Shows Digital Mammogram Benefits

A landmark breast cancer screening trial shows that digital mammography detected more cancers - up to 28 percent more - than screen film mammography in women 50 and younger, premenopausal and perimenopausal women, and women with dense breasts.

However, the trial, conducted by the American College of Radiology Imaging Network (ACRIN) in conjunction with the Center for Statistical Sciences at Brown Medical School, showed no difference between digital and film mammography in detecting breast cancer for the general population of women. The results were published in the New England Journal of Medicine.

With 49,528 women enrolled at 33 clinical sites, the trial is one of the largest breast cancer screening studies ever performed. Brown's Center for Statistical Sciences developed the study's statistical design and analyzed the results.

"The data show that digital mammography is, on average, as good at detecting breast cancer as film mammography - and in some important subgroups of women, digital performs even better," said Constantine Gatsonis, network statistician for ACRIN, professor of community health and applied mathematics at Brown, and an author of the New England Journal article.

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon